ERBB2 and cancer: Given that we found that expression of β2-chimaerin in breast cancer epithelial cells reduces E-cadherin, we asked whether ablation of β2-chimaerin in MMTV-Neu mice could delay cancer progression by increasing E-cadherin levels.